Tracy Odom, Clinical Nurse Specialist - Family Health Medicare: Accepting Medicare Assignments Practice Location: 24245 5th Ave, Florala, AL 36442 Phone: 334-574-0208 Fax: 334-574-0212 |
News Archive
The PATH Malaria Vaccine Initiative (MVI) announced today that it has entered into a collaboration with Dutch biopharmaceutical company Crucell N.V. and GlaxoSmithKline (GSK). This collaboration is aimed at developing a second-generation vaccine against malaria—a deadly disease that kills close to 800,000 people annually, most of them young children under age five in Africa. MVI drives the development of malaria vaccines by joining its scientific, managerial, and field expertise with companies, universities, and governments to test potential malaria vaccines and invest in those with the most promise.
Renato Corporation (FRANKFURT: 4OZ) has entered into negotiations to acquire up to 50% of Vanguard Pharmaceutical Corporation. "By acquiring Vanguard, Renato Corporation will have an existing infrastructure in place to market its generic pharmaceuticals to Latin and South America," said Mr. Morkunas.
Nationally, family premiums for employer-sponsored health insurance increased 119 percent between 1999 and 2008, and could increase another 94 percent to an average $23,842 per family by 2020 if cost growth continues on its current course, according to a new Commonwealth Fund report.
Colon cancer cells deficient in p53, one of the most important control proteins in cell growth, activate a particular metabolic pathway to adapt to the lack of oxygen and nutrients inside the tumor. Statins, which are often prescribed to lower cholesterol, block this metabolic pathway and cause the cancer cells to die, as scientists from the German Cancer Research Center have now discovered.
Biotech racked up impressive gains for both the month of March and the first quarter of 2010. The Burrill Biotech Select Index posted a 3.7 percent jump in value in March and an 8 percent overall gain for Q1 '10.
› Verified 9 days ago